A Phase I/IIA, Open-Label, Three-Stage Study to Investigate the Safety, the Efficacy and the Pharmacokinetics of Niclosamide Enemas in Subjects With Active Ulcerative Proctitis or Ulcerative Procto-Sigmoiditis
Phase of Trial: Phase I/II
Latest Information Update: 09 Aug 2019
Price : $35 *
At a glance
- Drugs Niclosamide (Primary)
- Indications Ulcerative proctitis; Ulcerative proctosigmoiditis
- Focus Adverse reactions
- Sponsors First Wave Bio
- 05 Aug 2019 Planned End Date changed from 1 Dec 2019 to 1 Dec 2020.
- 05 Aug 2019 Planned primary completion date changed from 1 Dec 2019 to 1 Dec 2020.
- 16 May 2018 New trial record